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Introduction: One of the main issues in the medical field and clinical practice is the development 
of novel and effective treatments against infections caused by antibiotic-resistant bacteria. 
One avenue that has been approached to develop effective antimicrobials is the use of silver 
nanoparticles (Ag-NPs), since they have been found to exhibit an efficient and wide spectrum 
of antimicrobial properties. Among the main drawbacks of using Ag-NPs are their potential 
cytotoxicity against eukaryotic cells and the latent environmental toxicity of their synthesis 
methods. Therefore, diverse green synthesis methods, which involve the use of environmentally 
friendly plant extracts as reductive and capping agents, have become attractive to synthesize 
Ag-NPs that exhibit antimicrobial effects against resistant bacteria at concentrations below 
toxicity thresholds for eukaryotic cells. 
Purpose: In this study, we report a green one-pot synthesis method that uses Acacia rigidula 
extract as a reducing and capping agent, to produce Ag-NPs with applications as therapeutic 
agents to treat infections in vivo. 
Materials and methods: The Ag-NPs were characterized using transmission electron 
microscopy (TEM), high-resolution TEM, selected area electron diffraction, energy-dispersive 
spectroscopy, ultraviolet–visible, and Fourier transform infrared. 
Results: We show that Ag-NPs are spherical with a narrow size distribution. The Ag-NPs 
show antimicrobial activities in vitro against Gram-negative (Escherichia coli, Pseudomonas 
aeruginosa, and a clinical multidrug-resistant strain of P. aeruginosa) and Gram-positive 
(Bacillus subtilis) bacteria. Moreover, antimicrobial effects of the Ag-NPs, against a resistant P. 
aeruginosa clinical strain, were tested in a murine skin infection model. The results demonstrate 
that the Ag-NPs reported in this work are capable of eradicating pathogenic resistant bacteria 
in an infection in vivo. In addition, skin, liver, and kidney damage profiles were monitored 
in the murine infection model, and the results demonstrate that Ag-NPs can be used safely as 
therapeutic agents in animal models. 
Conclusion: Together, these results suggest the potential use of Ag-NPs, synthesized by green 
chemistry methods, as therapeutic agents against infections caused by resistant and nonresistant 
strains.
Keywords: silver nanoparticles, green synthesis, in vitro antibacterial activity, in vivo 
antibacterial activity, skin infection, toxicological study
Introduction
Over the past few decades, there has been a growing interest in exploring alternative 
strategies to design and develop new antimicrobials due to the increased incidence in 
microbial resistance against commonly used antibiotics.1,2 The field of nanotechnology 
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offers a toolbox of synthesis and design strategies to develop 
antimicrobial nanotherapeutics with tailored antimicrobial 
properties to counterattack the problem of antimicrobial resis-
tance. Several reports have shown that nanoparticles made up 
of different noble metals can be used to kill both resistant and 
nonresistant bacterial strains.87–89 The large surface area-to-
volume ratio exhibited by these systems at the nanoscale has 
been hypothesized to be one of the bases of the antimicrobial 
effects against a broad spectrum of microorganisms.1 Silver 
nanoparticles (Ag-NPs) have obtained considerable atten-
tion due to their attractive physicochemical properties2,3 and 
remarkable antimicrobial effects exhibited against Gram-
negative and Gram-positive multidrug-resistant bacteria.4 The 
bactericidal effect of silver in its various chemical forms has 
been exploited since ancient civilizations;5 during the 18th 
century, silver was commonly used to treat infected ulcers, 
and more recently, in the early 1920s, Ag-NPs were included 
for wound treatment by the US Food and Drug Administra-
tion6 due to their strong toxicity against a wide range of 
microorganisms.7–9 There are various mechanisms that have 
been linked to the toxicity of silver compounds against micro-
organisms, among the most common are direct disruptive 
interactions with the cell membrane and DNA2 and the trigger 
of biochemical cascades that lead to free radical production, 
altering cell membrane permeability.10 In the case of Ag-NPs, 
it has been shown that there is a correlation between size and 
the exhibited antimicrobial effect.2 Nevertheless, the use of 
Ag-NPs for antimicrobial therapies has two major drawbacks: 
the toxicity exhibited to eukaryotic and mammalian systems 
and the toxicity of the chemical synthesis to produce them. 
Therefore, there have been efforts toward the development 
of greener synthesis processes to produce Ag-NPs11,12 with 
tailored properties that reduce toxicity against eukaryotic 
systems.13 Although there are various methods to synthesize 
Ag-NPs, including chemical reduction,14 photochemical 
reduction,15,16 electrochemical reduction,17 vaporization, and 
thermal synthesis,18 there is a growing interest in developing 
a green synthesis method to produce nanoparticles using 
biological systems19,20 and plant extracts.21 Notwithstanding 
the diversity of green synthesis approaches, the use of plant 
extracts, as reductive media for nanoparticle synthesis, is one 
of the most convenient routes.22,23
Ag-NPs have been synthesized using extracts obtained 
from different plants such as Acorus calamus (rhizome), 
Boerhaavia diffusa (whole plant), tea extract (leaves), Tribulus 
terrestris (fruit), Aloe vera (leaves), Eucalyptus hybrid (peel), 
Memecylon edule (leaves), and Citrus sinensis (peel).24 
In fact, within the last decade, hundreds of plant extracts have 
been reported to be effective reducing agents in the synthesis 
of Ag-NPs.25 These methods have been widely explored since 
they provide environmentally friendly and cost-effective 
routes to the synthesis of metallic nanostructures, in addition 
to being easily scalable production processes.26–28 In this study, 
we developed a green synthesis method to produce Ag-NPs 
using the extract of an Acacia rigidula plant. This plant is 
commonly known as blackbrush acacia, and it is a shrub that 
can be found in the regions of west and southwest Texas, as 
well as the Mexican northeastern region.29 Although there 
is limited information on the chemical composition of the 
A. rigidula plant,30 gums and condensed tannins are the most 
characterized parts in the literature.31 Forty-four amines and 
alkaloids,29 such as phenethylamines, have been identified 
in A. rigidula. These components have been associated with 
promotion of weight loss; therefore, both the A. rigidula plant 
and its extracts have been extensively used as dietary supple-
ments.30 Furthermore, forages from A. rigidula have been 
widely explored as a protein supplement to feed cattle.32,33 
It was then interesting to explore, in this study, the potential 
use of the extract, obtained from waste parts of the A. rigidula 
plant (roots and stems), as a reducing and stabilizing agent in 
the synthesis of Ag-NPs. The successfully obtained Ag-NPs 
showed antimicrobial activity in vitro against Gram-negative 
bacteria (Escherichia coli, Pseudomonas aeruginosa, and a 
multidrug-resistant P. aeruginosa strain) and Gram-positive 
bacteria (Bacillus subtilis). Moreover, in vivo studies showed 
promising antimicrobial effects of Ag-NPs in a murine skin 
infection model (using a P. aeruginosa clinical resistant 
strain). In addition, an in vivo toxicological study was carried 
out to verify the safety of using Ag-NPs; the results demon-
strate them to be a promising treatment for skin infections 
in the clinic. The combined results presented in this work 
contribute toward the development and synthesis of alterna-
tive antimicrobial agents, nanotherapeutics, to treat infections 
caused by clinical multidrug-resistant strains.
Materials and methods
Biological materials
Stems and roots from the A. rigidula plant were collected in 
Nuevo León, Mexico. Gram-negative bacteria used in the 
antimicrobial assays were E. coli American Type Culture 
Collection (ATCC)-11229, P. aeruginosa ATCC 27853, and 
a clinical multidrug-resistant P. aeruginosa isolated at the 
San Vicente Hospital in Monterrey, Nuevo León, Mexico. 
The Gram-positive bacterium used in the antimicrobial assays 
was B. subtilis ATCC 23857.
Bacteria cultures were grown for 20 h at 37°C and 
150 rpm (Lab Companion IS-971). After incubation, cultures 
were diluted 1:250 in fresh medium until an optical density 
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(OD
600
) of 0.2±0.02 was reached, adjusting with fresh 
medium if necessary to reach a cell concentration range 
between 107 and 108 cells/mL. The resulting suspension was 
then diluted (1:100) with fresh medium, obtaining the bacte-
rial working solution. Absorbance was measured using an 
ultraviolet–visible (UV–Vis) spectrophotometer (OPTIZEN 
2120 UV plus), and cell number was monitored by the plate-
counting method, measured by serial dilutions.
synthesis of ag-NPs
A. rigidula extract preparation
To prepare the extract, 5 g of stems and roots from the A. rigidula 
plant were mixed in 50 mL of distilled water. The mixture was 
then heated in a hotplate (Lab Companion HP-3100), until 
boiling, for 20 min. During the extraction time, agitation was 
performed using a magnetic stirrer. Once the infusion cooled, 
the extract was transferred to a 50-mL corning tube and cen-
trifuged (Sorvall™ Leyend™ XFR; Thermo Fisher Scientific, 
Waltham, MA, USA) at 9,000 rpm for 10 min. Then, the super-
natant was separated and vacuum-filtered (WP6111560; Merck 
Millipore, Billerica, MA, USA) using filter paper (Ahlstrom, 
Stockholm, Sweden). The obtained filtrate was stored at 4°C 
(Nor-Lake Scientific, Hudson, WI, USA).
ag-NPs preparation
A total of 10 mL of AgNO
3
 0.1 M and 3 mL of A. rigidula 
extract were mixed in a 50 mL corning tube and heated in a 
hotplate for 1 h at 60°C. The formation of the Ag-NPs was 
monitored and determined through a change of appearance 
(color) of the mix that changed from transparent to brownish. 
The resulting solution with the Ag-NPs was centrifuged at 
9,000 rpm for 15 min. Then, the product was washed with 
ethanol and was stored at −75°C for 24 h in an ultralow tem-
perature freezer (Sanyo MDF-U53VA). Then, the product 
was lyophilized (FreeZone 6; Labconco, Kansas City, MO, 
USA) for 24 h to obtain the purified Ag-NPs.
ag-NPs stability experiments
UV–Vis spectra (wavelength range from 200 to 800 nm) of 
the A. rigidula extract and the Ag-NPs (solution of 1 mg/mL 
in distilled water as a dispersive medium) were measured using 
a Multiskan G0 UV–Vis spectrophotometer (Thermo Fisher 
Scientific). To test stability of the synthesized Ag-NPs, UV–Vis 
spectra were obtained from Ag-NPs’ solution at two different 
time points (first time point right after being synthesized and 
second time point after being stored in solution for 4 months).
characterization techniques
Morphological and structural characteristics of the Ag-NPs 
were studied with conventional transmission electron 
microscopy (TEM) and high-resolution TEM (HRTEM) 
and selected area electron diffraction (SAED) using an FEI-
TITAN 80–300 kV microscope operated at an accelerating 
voltage of 300 kV. The specimen for these studies was pre-
pared by depositing and evaporating a drop of the colloidal 
solution (Ag-NPs 1 mg/mL), previously dispersed by means 
of an ultrasonic cleaner (Bransonic® Branson 2510MT; 
Bransonic, Dansbury, CT, USA), onto lacey carbon-coated 
copper grids. The elements present in the samples were 
determined using an energy-dispersive spectrometry (EDS) 
analyzer integrated in the transmission electron microscope. 
In relation to the particle size, TEM images were used to 
measure the diameter of Ag-NPs to estimate the size distribu-
tion of our nanoparticles using the image processing software 
ImageJ – National Institute of Health (NIH). The images 
obtained from the SAED patterns were interpreted with 
simulated patterns using the Web-based Electron Microscopy 
Application Software (Web-EMAPS).34
Furthermore, UV–Vis spectra (wavelength range from 200 
to 1,000 nm) of the Ag-NPs (solution of 1 mg/mL in distilled 
water as a dispersive medium) were obtained using a Multiskan 
G0 UV–Vis spectrophotometer. To obtain information related 
to the interaction between A. rigidula extract and Ag+ ions to 
produce the Ag-NPs and their capping, infrared spectra were 
obtained for the extract alone and for the Ag-NPs. The spectra 
were acquired using a Fourier transform infrared (FT-IR) spec-
trophotometer (Nicolet™ iS™ 50; Thermo Fisher Scientific). 
Samples from the extract solution and from a 1 mg/mL sample 
of Ag-NPs were freeze-dried with a lyophilizer (FreeZone 6) 
for 24 h to obtain the samples, which were diluted in KBr, 
using the attenuated total reflectance (ATR) method.
In vitro antibacterial test
Minimum inhibitory concentrations (MIcs)
MIC assays were assessed in 96-well plates (Costar; Corning 
Incorporated, Corning, NY, USA) based on a modified meth-
odology reported previously35 and National Committee for 
Clinical Laboratory Standards.36 Stocks of the Ag-NPs were 
prepared at a final concentration of 1 mg/mL using distilled 
water as the vehicle. To perform the MIC tests, Ag-NPs’ stock 
solution was added to reach a 0.5 mg/mL concentration within 
a final volume of 200 μL. Next, serial dilutions of the Ag-NPs 
were performed by taking 100 μL from the previous solution to 
every next well, with 100 μL of culture media, and discarding 
the last 100 μL from the last dilution so the tested concentra-
tions were 0.25–4.88×10−4 mg/mL for Ag-NPs. Then, 100 μL 
of the bacteria working solution was added to each test well 
to achieve a final concentration of 105 cells/mL, followed by 
incubation at 37°C and 150 rpm. After 20 h of incubation 
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at 37°C, the MIC was measured. The MIC for Ag-NPs was 
defined as the concentration at which no significant growth 
was observed by the naked eye. All tests, and their respective 
control samples, were performed in triplicate.
Minimum bactericidal concentration (MBc)
To assess the bactericidal activity of the synthesized Ag-NPs, 
1, 2, and 4 times, the Ag-NPs’ MIC was tested against the bac-
terial strains. In a typical assay, an overnight culture of each 
strain was diluted 1:250 in 5 mL of fresh Luria Broth (LB) 
medium, followed by incubation at 37°C and 150 rpm, until it 
reached exponential phase at a critical OD (OD
600
 =0.18–0.22). 
A total of 20 μL of the exponential cultures were transferred to 
96-well plates, which contained the Ag-NP treatments, to be 
incubated at 37°C and 150 rpm for 20 h. After incubation, the 
colony-forming units (CFUs) per milliliter were determined 
through the drop count method. Tenfold diluted aliquots were 
obtained, and then, three 10 μL drops of each of the diluted 
samples were placed on LB agar plates. The plates were then 
incubated at 37°C for 24 h, and viable bacterial colonies were 
counted. All tests and their respective control samples were 
performed in replicates of three.
Fluorescence microscopy imaging 
of treated and untreated bacteria
Fluorescence microscopy of the treated and untreated bacteria 
was carried out based on the methodology described by 
Vazquez-Rodriguez et al.37 A total of 105 bacterial cells of 
the resistant P. aeruginosa clinical strain were treated with 
Ag-NPs, at 0, 0.5, 1, and 2 times the MIC, for 20 h at 37°C 
and 150 rpm. After the 20 h treatment, bacterial cells were 
stained with 5 μg/mL of propidium iodide (PI) for 1 h at 
37°C and 150 rpm. A total of 20 μL of the treated samples 
and the control were placed and spread in glass slides, pre-
viously cleaned with 96% ethanol, allowing the samples 
to air dry and fix by adding 200 μL of methanol for 2 min. 
The methanol excess was decanted, and the slides were 
then washed twice with phosphate-buffered saline (PBS). 
Micrograph images were obtained under DM3000 (Leica 
Microsystems, Wetzlar, Germany) using the 100× objective 
with an Y3 ET filter system.
In vivo antibacterial test
animals
Female adult Wistar rats (200–250 g) were used and main-
tained in stainless steel cages with a 12 h light/dark regime. 
All the experimental animals were handled ethically (refer 
the “Ethics approval and informed consent” section).
In vivo skin infection model
The in vivo experiment based on a tape stripping infec-
tion model38 was performed with some modifications. The 
rats were anesthetized with pentobarbital (Pentosedal; 
Laboratorios Maver, Ciudad de México, Mexico) injecting 
intraperitoneally 2.5 mL/kg of body weight (bw). Once 
anesthetized, the back of the rats was shaved in an area of 
3 cm2 with a trimmer (274 Series A; Oster, Boca Raton, 
FL, USA). Next, an area of 2.5 cm2 of the hairless skin of 
the rats was tape stripped five times in succession using 
an elastic adhesive bandage (Sedasiva®; BSN Medical, 
Yumbo, Colombia). Damage on the skin was defined as 
the reddening and glistening of the skin with the absence 
of regular bleeding. This procedure was performed in all the 
animals used in the experiment. After that, to cause infec-
tion, bacterial inoculation was performed by placing, in the 
wound produced with the tape stripping process, 100 μL 
of a 107 cells/mL P. aeruginosa culture in log phase. The 
P. aeruginosa culture was obtained from an overnight culture 
grown as described previously in the MBC description of the 
Materials and methods section.
experimental design
The rats were divided into three groups (three animals per 
experimental group [n=3]): the control group (with the wound 
on the skin without infection, and treated with 100 μL of 
saline solution every 24 h for 3 days in the damaged zone), 
the infected group (treated in the damaged zone with 100 μL 
of the clinical strain of P. aeruginosa culture), and the Ag-
NP-treated group (treated with 100 μL of Ag-NPs solution 
at 200 parts per million [ppm] every 24 h for 3 days after 
infection with the clinical strain of P. aeruginosa in the 
damaged zone). During all the experiments, the rats were 
kept with food and water ad libitum at room temperature 
(24°C±1°C).
The rats were anesthetized and sacrificed 24 h after the 
third day of treatment, and 300 mg of the wound (~1 cm2) 
was removed and homogenized (Tissue-Tearor 398; BioSpec, 
Bartlesville, OK, USA) with 3 mL of phosphate buffer 
(100 mg
wound
/mL
buffer
).
Finally, 10 μL of homogenates (to have a 1:100 dilution) 
were used to carry out a pour plate technique to determine 
the CFUs of living bacteria and to compare these results 
among the study groups.
In vivo toxicological study
experimental design
To demonstrate the safety in the use of the Ag-NPs pro-
duced in this study, four groups of female adult Wistar rats 
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(200–250 g) with three animals per group (n=3) were used 
to carry out the toxicological test. The four groups included 
the control group and three groups treated with the Ag-NPs 
at different concentrations. In this experiment, the rats were 
injured based on the tape stripping infection model described 
previously in the in vivo skin infection model methodology. 
Briefly, the pentobarbital was administered intraperitoneally 
to the rats (2.5 mL/kg bw) to anesthesize them. After that, a 
3 cm2 area from the back of the rats was shaved using a trimmer 
in which 2.5 cm2 of the shaved part was tape stripped five 
times with an elastic adhesive bandage until the hairless skin 
reddened and glistened, but there was no bleeding observed. 
This procedure was done in all of the animals used in this 
experiment. To start the test, the animals in the control group 
were treated with 100 μL of saline solution on the wound 
produced by the tape stripping procedure, while the rats in 
the other three tested groups were treated with 100, 200, and 
400 ppm of Ag-NPs, respectively. The treatment consisted of 
applying either saline solution or the Ag-NPs solution (at the 
respective concentration) directly on the wound until the solu-
tion was absorbed through the skin. All groups were treated in 
the damaged zone every 24 h for 3 days; the same way as the 
antibacterial assay was performed. Throughout the experi-
ment, the rats were kept with food and water ad libitum at 
room temperature (24°C±1°C). Then, 24 h after the third day 
of treatment, urine samples were collected in vessels attached 
with metabolic cages (3700M020; Tecniplast, Buguggiate 
(VA), Italy) in which the rats were placed. Afterward, with 
the rats previously anesthetized, blood samples were also 
obtained and the rats were sacrificed.
Biochemical assays
In order to test kidney and liver functions of the rats exposed 
to Ag-NPs, the urine volume was measured, and with their 
respective methods, the concentration of creatinine,39,40 
glucose,41 and proteins42 in urine was also measured using a 
UV–Vis spectrophotometer (DMS 80; Varian, Palo Alto, CA, 
USA). For the case of blood plasma samples, the concentra-
tion of creatinine,39,40 albumin,43 alanine aminotransferase 
(ALT),44 and aspartate aminotransferase (AST)45 was mea-
sured using a UV–Vis spectrophotometer (DMS 80).
Likewise, during the experiment, the appearance of the 
skin (wound) of the experimental groups exposed to Ag-NPs 
was observed and compared with the control group.
statistical analysis
For the in vivo study (antibacterial and toxicological experi-
ments), the significance of the differences between group 
averages was calculated with the two-tailed Student’s t-test 
for grouped data with an analysis of variance (ANOVA) 
posttest. The calculations and graphs were prepared using 
the Prism 4 software (GraphPad Software, Inc., La Jolla, 
CA, USA).
ethics approval and informed consent
Animal care and experimentation practices at the Universidad 
Autónoma de Aguascalientes are constantly evaluated by 
the Animal Care and Use Committee, adhering to the offi-
cial Mexican regulations (NOM-062-ZOO-1999). Mexican 
regulations are in strict accordance with the recommendations 
in the Guide for the Care and Use of Laboratory Animals of 
the NIH and The Weatherall Report of the USA to ensure 
compliance with established international regulations and 
guidelines. Experimental protocols were approved by the 
local Institutional Bioethical Committee. At the end of 
experiments, animals were sacrificed by using an excess of 
sodium pentobarbital anesthesia (40 mg/kg bw). Efforts were 
made to minimize suffering.
Results
characterization of ag-NPs
Ag-NPs were produced in an aqueous solution containing 
an extract from A. rigidula. As can be observed in the TEM 
and HRTEM micrographs (Figure 1A and B), the Ag-NPs 
display homogeneous spherical shapes (Figure 1A and B). 
An SAED pattern of the Ag-NPs showed spotty rings that 
can be attributed to the (111), (200), (220), (311), and 
(331) planes of a face-centered cubic (fcc) metallic Ag-NP 
(Figure 1C). The Ag-NPs exhibit a diameter size distribution 
that ranges from 8 to 66 nm with a mean of 22.46 nm and a 
standard deviation of 10.83 nm (Figure 1D). The histogram 
in Figure 1D shows that most of the Ag-NPs have a diameter 
size between 15 and 25 nm, which corresponds to a narrow 
homogeneous distribution.
Further characterization of the nanoparticles by EDS 
analysis shows the presence of Ag, which confirms the pres-
ence of Ag-NPs (Figure 2). In the EDS analysis, other ele-
ments such as C and Cu were detected, where C corresponds 
to the organic matrix and lacey carbon of the TEM grid and 
Cu is observed since the grid used for the TEM analysis is 
made up of Cu (Figure 2).
The UV–Vis spectra of the A. rigidula alone, and the 
Ag-NPs produced by reduction and capping using the 
A. rigidula extract, are shown in Figure 3A. The Ag-NPs 
exhibit a plasmon resonance spectrum with an absorption 
band between 430 and 480 nm. Furthermore, Figure 3A 
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shows a dotted UV–Vis spectra that corresponds to the Ag-
NPs’ sample that was stored in solution for 4 months. As can 
be observed, the spectra present minimal changes and keep 
their absorption peak between 430 and 480 nm. This result 
demonstrates the stability of the Ag-NPs after being stored for 
long time periods. FT-IR characterization of the extract alone 
(Figure 3B) and the Ag-NPs synthesized with the extract 
(Figure 3C) showed that both samples contained functional 
groups that have been previously reported to be present in 
an A. rigidula extract.46–51 Some of the characteristic peaks 
observed in both samples include (Figure 3B and C) a 
prominent peak at 3,419 cm−1 due to the stretching of O–H in 
alcohols and phenols; two peaks at 2,929 and 2,854 cm−1 due 
to the stretching of CH
3
− and CH
2
− in aliphatic compounds; 
one peak at 1,614 cm−1 due to the bending of N−H in amines; 
one peak at 1,517 cm−1 corresponding to the stretching of 
C=C in aromatic compounds; another peak at 1,447 cm−1 
attributed to −C−N groups; one peak at 1,384 cm−1 due to 
the symmetric deformation of CH
3
 in aromatic and aliphatic 
compounds; another peak at 1,285 cm−1 corresponding to 
the wagging of C−H in alkyl halides; a peak at 1,250 cm−1 
due to the stretching of C=O groups; two peaks at 1,114 and 
1,068 cm−1 due to the stretching of C−O in polysaccharides; 
?
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Figure 1 electron microscopic characterization of crystalline structure, size, and shape distributions of the ag-NPs.
Notes: (A) low-resolution TeM micrograph of the ag-NPs. (B) high-resolution TeM micrograph of the ag-NPs. (C) saeD pattern of the ag-NPs with the rings labeled. 
(D) histogram of the particle diameter size distribution of the ag-NPs.
Abbreviations: ag-NPs, silver nanoparticles; saeD, selected area electron diffraction; TeM, transmission electron microscopy.
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Figure 2 eDs spectrum of the ag-NPs with the peaks labeled.
Abbreviations: ag-NPs, silver nanoparticles; eDs, energy-dispersive spectrometry.
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three peaks at 894, 823, and 767 cm−1 due to the bending 
of =CH in aromatic hydrocarbons; and one peak at 689 cm−1 
attributed to the bending of C−H in alkynes.
In vitro antimicrobial activity of ag-NPs in 
gram-negative and gram-positive bacteria
MIC and MBC assays were performed under the same cul-
ture conditions for each of the bacteria tested in this work. 
B. subtilis had the lowest MIC with a value of 0.48 ppm. For 
P. aeruginosa, the obtained MIC was 15.6 ppm, twice the MIC 
obtained for the clinical multidrug resistant bacteria of the 
same strain. The MIC value obtained for E. coli was 62.5 ppm, 
the highest of all the MICs determined. The MIC values 
obtained in this experiment are summarized in Table 1.
Bactericidal activity was tested through MBC assays 
using Ag-NPs at different treatment concentrations linked 
to the MICs reported. As can be observed in Figure 4A–D, 
E. coli and B. subtilis show the lowest MBC (two times the 
MIC). In addition, with a statistical significance (P,0.05), 
even at one MIC, the treatments show bactericidal activity. 
For P. aeruginosa strains, the MBCs were found at four times 
the MICs. However, as observed for E. coli and B. subtilis, 
bactericidal activity can be observed as low as the concentra-
tion corresponding to one MIC. Thus, the Ag-NPs produced 
by A. rigidula extract show bactericidal activity in both 
Gram-negative and Gram-positive bacteria.
Morphological changes in P. aeruginosa 
after treatment with ag-NPs
Since antimicrobial activity has been extensively linked to bac-
terial envelope damage, morphological changes were explored 
in a clinically relevant multidrug-resistant P. aeruginosa 
that was treated with Ag-NPs. Bacterial membrane disrup-
tion caused by the Ag-NPs treatments was tested through a 
fluorescence PI stain assay.10 As can be observed in Figure 5, 
when compared with the untreated bacteria (Figure 5A), the 
florescent micrographs (Figure 5B–D) show a general qualita-
tive increased fluorescence for all the treatments (0.5, one, and 
two times the MIC). These results suggest that bacterial mem-
brane integrity is compromised either directly or as a conse-
quence of the antimicrobial activity exhibited by the Ag-NPs.
In vivo antimicrobial activity of ag-NPs in 
a murine skin infection model triggered 
by a P. aeruginosa clinical strain
A murine skin infection model in rats was performed to test 
the ability of Ag-NPs to treat a topical infection caused by a 
resistant clinical strain (P. aeruginosa). As can be observed 
in Figure 6, there is a statistically significant higher amount 
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Figure 3 Physical characterization of the ag-NPs.
Notes: (A) UV–Vis spectra of Acacia rigidula extract and ag-NPs biosynthesized. 
(B) FT-Ir spectra of A. rigidula extract. (C) FT-Ir of ag-NPs synthesized by the 
A. rigidula extract. The band and peaks are labeled as follows: 1) 3,419, 2) 2,929, 
3) 2,854, 4) 1,614, 5) 1,517, 6) 1,447, 7) 1,384, 8) 1,285, 9) 1,250, 10) 1,114, 
11) 1,068, 12) 894, 13) 823, 14) 767, and 15) 689 cm−1.
Abbreviations: ag-NPs, silver nanoparticles; FT-Ir, Fourier transform infrared; 
UV–Vis, ultraviolet–visible.
Table 1 Nominal MIcs of ag-NPs for the four different strains 
tested in this work
Bacteria MICs (ppm)
Escherichia coli aTcc-11229 62.5
Pseudomonas aeruginosa aTcc 15.6
P. aeruginosa (clinical multidrug-resistant strain) 7.8
Bacillus subtilis aTcc 0.5
Abbreviations: ag-NPs, silver nanoparticles; MIcs, minimum inhibitory 
concentrations.
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of CFUs present in the group infected with the clinical strain 
of P. aeruginosa with respect to the control group (P,0.05). 
Moreover, the group infected with P. aeruginosa and treated 
with Ag-NPs exhibits a number of CFUs statistically similar 
to the control group and statistically much lower than the 
group infected with P. aeruginosa and not treated with the 
Ag-NPs (P,0.05).
In vivo toxicological assay of the ag-NPs
A murine toxicity infection model in rats was performed 
to test the toxicity of Ag-NPs during treatment of a topical 
infection caused by a resistant clinical strain (P. aeruginosa). 
For the toxicity study, different parameters of renal function 
were evaluated. These parameters included urinary volume, 
urinary concentrations of proteins, glucose and creatinine 
and blood concentrations of creatinine. The results shown 
in Figure 7 demonstrate that the control urine volumes 
(Figure 7A), as well as glucose (Figure 7B), total proteins 
(Figure 7C), and creatinine (Figure 7D) concentration levels 
in the urine, are statistically similar (P,0.05) to the values 
obtained for all the treatments with different Ag-NP concen-
trations (100, 200, and 400 ppm). The same trend is observed 
for creatinine levels shown in the blood (Figure 7E). In addi-
tion, no statistically significant differences (P,0.05) were 
observed between the groups of rats treated with the Ag-NPs 
and the control groups in the parameters tested to evaluate 
hepatic function (albumin [Figure 8A], ALT [Figure 8B], and 
AST [Figure 8C] concentrations in blood plasma).
Finally, no differences were observed in the appearance 
and characteristics of the skin between the treated animals 
at any of the concentrations of Ag-NPs.
Discussion
synthesis and characterization of ag-NPs
It is well-known that plant crude extracts contain secondary 
metabolites, such as phenolic acids, flavonoids, alkaloids, 
and terpenoids, that can trigger redox reactions, such as those 
that take part in the synthesis of Ag-NPs, which are involved 
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Figure 4 MBc of ag-NPs tested at 1, 2, and 4 times the MIc.
Notes: The image reports the MBcs of ag-NPs against (A) Escherichia coli, (B) Bacillus subtilis, (C) Pseudomonas aeruginosa, and (D) a clinical resistant strain of P. aeruginosa. 
*P,0.05.
Abbreviations: ag-NPs, silver nanoparticles; cFUs, colony-forming units; MBcs, minimum bactericidal concentrations; MIcs, minimum inhibitory concentrations.
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in the reduction in silver ions into metallic silver atoms 
that further assemble into nanostructures.52 Many species 
of the Acacia genus contain different types of secondary 
metabolites that can be used as reducing agents such as 
amines and alkaloids, nonprotein amino acids, cyanogenic 
glycosides, cyclitols, fatty acids and seed oils, fluoroacetate, 
gums, terpenes, diterpenes, phytosterols, triterpene genins 
and saponins, hydrolyzable tannins, condensed tannins, 
and flavonoids.31 However, the polysaccharides or gums 
and complex phenolic compounds or condensed tannins are 
among the most studied and most recognized.31 Thus, the 
effective reducing capability of the A. rigidula extract used 
in the synthesis of Ag-NPs can be attributed to the phenolic 
compounds, saponins, and flavonoids.
The homogeneity of the size distributions observed for the 
Ag-NPs reported in this work compares with other works in 
the literature that report Ag-NPs produced by green synthesis 
methods. Ag-NPs have been obtained with sizes between 50 
and 250 nm using Carica papaya leaf extract;53 with average 
sizes 23±12, 32±24 and 19±22 nm using Illicium verum 
(star anise) seed extracts,54 and average size 73 nm using an 
aqueous extract of Tephrosia tinctoria.55 Regarding spherical 
shape homogeneity, our synthesis method was compared with 
that of other works where spherical Ag-NPs are synthesized, 
such as in the case of other green synthesis methods that 
employ leaf extracts of Saraca indica,56 Ficus carica,57 and 
Cocos nucifera.58
30 µM 30 µM
30 µM30 µM
A B
DC
Figure 5 Fluorescence microscopy imaging of clinical resistant strain of Pseudomonas aeruginosa.
Notes: Microscopic results show a PI assay of the clinical resistant strain of P. aeruginosa treated with ag-NPs at the following concentrations: (A) 0, (B) 0.5 MIc, (C) 1 MIc, 
and (D) 2 MIc.
Abbreviations: ag-NPs, silver nanoparticles; MIcs, minimum inhibitory concentration; PI, propidium iodide.
0
0.5
1
1.5
2
2.5 * *
C
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s 
×1
0–
6
Control Nontreated Ag-NPs treated
Figure 6 antimicrobial effects of ag-NPs in a murine skin infection model.
Notes: cFUs obtained from the in vivo antibacterial test. The mean values are 
expressed (±seM) (*P,0.05).
Abbreviations: ag-NPs, silver nanoparticles; cFUs, colony-forming units; seM, 
standard error of the mean.
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The chemical and physical characterization of the Ag-NP 
samples suggests that the Acacia extract is capable of not 
only reducing the silver ions but also capping the Ag-NPs 
and stabilizing their surface. This is a phenomenon not com-
monly observed, but it has been previously reported that when 
both reducing and capping effects are present in an extract, 
it allows a tighter control of the nanoparticle sizes obtained 
and prevents further aggregation of the samples in time.52,59
The well-defined spotty rings correspond to (111), 
(200), (220), (311), and (331) planes of fcc metallic silver 
(Joint Committee on Powder Diffraction Standards file 
no 87-0720), while EDS analysis demonstrates that the nano-
particles obtained are constituted of silver and makes evident 
their crystalline nature (Figures 1C and 2). Similar informa-
tion from the EDS and SAED analyses of Ag-NPs has been 
reported when using I. verum (star anise) seeds54 and extracts 
of Capsicum annuum var. aviculare (piquin) fruits.12
The UV–Vis spectrum of both the A. rigidula extract and 
the Ag-NPs shows that for the extract, the absorbance was 
low, but in the case of Ag-NPs, it displays the maximum 
absorbance at 444 nm, indicating that the extinction band is 
a result of the surface plasmon resonance (SPR) phenomenon 
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Figure 7 Parameters of renal function of Wistar rats treated with ag-NPs.
Notes: Test was performed for different concentrations of ag-NPs (100, 200, and 400 ppm), and different parameters of renal function are measured: (A) urinary volume, 
(B) urinary glucose concentration, (C) urinary total proteins concentration, (D) urinary creatinine concentration, and (E) blood plasma creatinine concentration. The mean 
values are expressed (±seM).
Abbreviations: ag-NPs, silver nanoparticles; seM, standard error of the mean.
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Figure 8 Parameters of hepatic function of Wistar rats treated with ag-NPs.
Notes: Test was performed for different concentrations of ag-NPs (100, 200, and 400 ppm), and different parameters of hepatic function are measured: (A) blood plasma 
concentration of albumin, (B) blood plasma concentration of alT, and (C) blood plasma concentration of asT. The mean values are expressed (±seM).
Abbreviations: ag-NPs, silver nanoparticles; alT, alanine aminotransferase; asT, aspartate aminotransferase; seM, standard error of the mean.
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produced by Ag-NPs (Figure 3A). These results correlate 
with previous reports that show a maximum absorption peak 
at 480 nm, when Ag-NPs were synthesized using T. tinctoria 
extract as a reducing agent,55 and an absorption peak at 
420 nm when Ag-NPs were produced using Chrysopogon 
zizanioides aqueous extract.59 Hence, these results agree with 
the Mie scattering theory about single spherical Ag-NPs well 
dispersed in water with different diameters.54 In this regard, 
the width of the peak obtained in the UV–Vis spectrum is 
mainly attributed to the size distribution and differences in 
the shape of the Ag-NPs.60 Furthermore, the UV–Vis spectra 
of a sample that was stored in solution for 4 months show 
a sustained maximum absorbance at ~450 nm (Figure 3A), 
strongly suggesting that Ag-NPs remain stable during con-
siderable long periods of time. Thus, the organic matrix of 
A. rigidula extract acts as an effective stabilizing agent.
In the case of the FT-IR spectroscopy (Figure 3B and 
C), the different functional groups observed in the Ag-NPs 
spectrum also appear in the A. rigidula extract. In addition, 
the peaks observed are in accordance with the different com-
ponents that the extract may contain, such as carbohydrates, 
flavonoids, and polyphenols, that can be carrying out the 
process of reduction in the Ag+ ions to produce Ag-NPs. 
Therefore, the characterization data strongly indicate the 
function of the extract as a capping and stabilizing agent of 
the Ag-NPs. Moreover, the results suggest the presence of the 
components of the extract in the surface of the Ag-NPs.
antibacterial test: in vitro and in vivo study
For .2,000 years, silver has been recognized for its medici-
nal properties. Hence, silver has been used as an antimicro-
bial agent due to its effectiveness against some pathogenic 
microorganisms and its lower toxicity in animal cells in 
comparison with other metals.24 Moreover, recently, there 
has been an increasing interest in the application of silver 
as nanoparticles, for medical applications, as an alternative 
antimicrobial agent. Taking into account the problem of 
multidrug resistance to the conventional antibiotics, both 
Gram-negative and Gram-positive bacteria have developed 
recently.61 For this reason, there is a need to search and 
produce more efficient antimicrobial agents that can fight 
strains of multidrug-resistant bacteria.62
The Ag-NPs produced by green synthesis with 
A. rigidula extract exhibited antimicrobial activity against 
Gram-negative bacteria (E. coli, P. aeruginosa, and the 
clinical strain of P. aeruginosa) and Gram-positive bacteria 
(B. subtilis) tested in our study (Table 1 and Figure 4A–D). 
Interestingly, the MIC values observed in our study for 
P. aeruginosa are similar to the values obtained by Ag-NPs 
produced from an aqueous extract of Phyllanthus amarus 
against several P. aeruginosa clinical strains,63 where MIC 
values varied from 6.25 to 12.5 ppm. MIC values obtained 
in this study for B. subtilis are lower than those previously 
reported, where a 12.5 ppm MIC value was observed with 
Ag-NPs obtained from an aqueous rhizome extract of 
Coptis chinensis.64 However, the same study showed lower 
MIC values for E. coli, where an MIC value of 25 ppm was 
reported.64 A similar MBC of the green synthesized Ag-NPs 
against the bacteria tested in this study was found using 
plant extracts as reducing and stabilizing agents.65–67 In this 
regard, it is possible to infer that Ag-NPs produced by an 
A. rigidula extract display effective antibacterial activity as 
bacteriostatic and bactericidal agents against both Gram-
positive and Gram-negative bacteria.
We hypothesized that Ag-NPs might be interacting with 
both membrane and cell wall components, impeding bacte-
rial growth. The PI assay results obtained by fluorescence 
microscopy (Figure 5A–D) show an increased fluorescence 
in the bacteria treated with Ag-NPs compared to the untreated 
control sample. This indicates that the Ag-NPs induce 
bacterial cell permeability by the disruption of cell mem-
brane integrity. Thus, this can be one potential antibacterial 
mechanism linked to the effective antimicrobial properties 
exhibited by Ag-NPs. In this context, alterations in perme-
ability and membrane structure have been mentioned as one 
mechanism of antimicrobial activity of Ag-NPs.68 Previ-
ous reports have shown that cell membrane damage of P. 
aeruginosa can be induced by Ag-NPs produced by green 
synthesis methods.69
For the in vivo study, we confirmed that the Ag-NPs’ anti-
bacterial activity involved a reduction of CFUs in the group 
treated with the Ag-NPs. In comparison, Ag-NPs elaborated 
by means of an aqueous extract of Caltropis procera fruit 
or leaves, administered to infant mice colonized with Vibrio 
cholerae or enterotoxic E. coli, significantly reduced from 
75 to 100 times the colonization rates of these pathogenic 
bacteria.70
Furthermore, nanobiocomposites of Ag-NPs synthetized 
with leaf extract of Syzygium cumini into a matrix of cel-
lulose nanocrystals from Dendrocalamus hamiltonii and 
Bambusa bambos leaves showed antibacterial activity and 
were effective in obtaining an accelerated wound healing 
on, in vivo, skin of male, Swiss albino mice.71 Moreover, 
flavonoid-loaded Ag-NPs produced by a Ricinus communis 
leaf extracted flavonoid mixture were efficient in curing a 
Staphylococcus aureus infection on a silkworm Bombyx 
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mori larvae.72 Therefore, molecules such as flavonoids have 
been found to be able to coat Ag-NPs,73,74 a similar to what 
we have seen in our study, and their presence in the surface 
could be a factor involved in the antimicrobial activity of 
these nanoparticles.
The main difference between Gram-negative and Gram-
positive bacteria is the thickness of the cell wall. Gram-
negative bacteria contain a thin peptidoglycan, 2–3 nm 
thick, between the outer membrane and the cytoplasmic or 
inner membrane,75 while Gram-positive bacteria possess a 
thicker peptidoglycan layer of ~30 nm thick, without outer 
membrane.76 In the case of B. subtilis (Gram-positive), growth 
inhibition can be attributed to interactions between Ag-NPs 
embedded in the cell wall, causing membrane permeability 
due to structural changes in the cell wall.77 In contrast, on 
Gram-negative bacteria such as E. coli and P. aeruginosa, the 
outer membrane is composed mainly of lipids and proteins, 
which are the first structures encountered by the Ag-NPs. 
Therefore, Ag-NPs could have adhered to these structures, 
altering their properties and integrity-forming gaps within 
the membrane, increasing its permeability.6 It is also well 
known that the membrane contains large amounts of sulfur-
containing proteins and their inactivation can play a role in 
the deterioration of the membrane produced by Ag-NPs.78,79 
Therefore, these kinds of proteins may be another target of 
the Ag-NPs, inactivating enzymes and contributing to the 
deterioration of the membrane.78,79 It has been reported that 
the antimicrobial activity of colloidal Ag-NPs is influenced 
by different particle characteristics such as size, shape, and 
capping agent.24,52,80 In this context, small sized Ag-NPs (as 
the Ag-NPs obtained in this study) have been reported to 
present a better bactericidal activity due to a greater binding 
surface in comparison to larger Ag-NPs.2 Moreover, the 
capping of the Ag-NPs produced in this study contains O−H 
functional groups (Figure 3) from polyphenol compounds 
present in the organic matrix. This functional group may 
produce damage and toxicity in the membrane and cell wall 
of the bacteria through oxidative stress by free radicals and 
reactive oxygen species (ROS).81 However, Ag-NPs alone 
are capable of producing ROS causing a microbial growth 
inhibition.82
Another mechanism that explains the toxicity of Ag-NPs 
against some bacteria refers to the release of Ag+ ions from 
the Ag-NPs. In fact, it has been reported that the toxicity of 
Ag-NPs with a size of 20–80 nm is predominantly due to the 
release of Ag+ ions.2,6 Since the Ag-NPs synthesized in this 
study (22.46 nm) are within the size range reported, it is possi-
ble that Ag+ ions release may also explain the growth inhibition 
shown here. This means that Ag+ ions could interact with 
membrane or cell wall components or participate in the gen-
eration of ROS. Hence, this mechanism can cause changes 
and damage in the permeability and physiology of bacteria. 
In addition, it has been shown that the release of Ag+ ions is 
the main antibacterial mechanism of toxicity of Ag-NPs.83
In vivo toxicological study
In an organism, the suitable functioning of its organs is very 
important to achieve a healthy balance maintaining the com-
position of its internal environment. This is largely achieved 
with the correct functioning of organs such as the kidney 
and liver. In the kidneys, the basic structural and functional 
units are the nephrons. They carry out their function by the 
following three fundamental processes: glomerular filtra-
tion, tubular reabsorption, and tubular secretion producing 
the final excretion of substances in the urine.84 In relation 
to the renal function parameters in urine assessed in this 
study, the kidneys regulate the volume (amount of body 
fluid), the concentration of glucose (associated with tubular 
function in nephrons), the concentration of total proteins 
(linked with glomerular filtration and general function of 
nephrons), and the concentration of creatinine both in plasma 
and urine (related with glomerular filtration rate in nephrons) 
in the organism. All the parameters measured in the treated 
samples were very similar to the values of the control group 
(Figure 7A–D). Thus, the Ag-NPs produced in our study did 
not produce any adverse or toxic effects in the nephrons and 
renal function of the animals treated.
Similarly, the liver is responsible for numerous vital 
functions for the proper functioning of higher order organ-
isms, where the metabolization of chemical substances and 
biliary excretion occur.84 Therefore, this work analyzed 
hepatic function parameters in blood plasma when rats were 
treated with the Ag-NPs. The concentration of ALT and AST 
(biomarker of hepatic cell necrosis) and the concentration 
of albumin (biochemical biomarker of damage and hepatic 
function) of the treated groups with Ag-NPs were similar 
to the values of control groups (Figure 8A–C). Thus, the 
Ag-NPs obtained in this study did not have any adverse 
or toxic effects in the hepatic function. These findings are 
in agreement with other results that show zero mortality, 
absence of abnormal reactions, and minimal effect on kidney 
and liver indices in male and female Sprague Dawley rats 
administered orally with 2,000 mg/kg bw of Ag-NPs pro-
duced by Sargassum siliquosum, indicating low toxicity of 
these nanoparticles.85 Moreover, in the same study, it was 
observed that a pretreatment with Ag-NPs prevented liver 
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cell damage caused by paracetamol at 100 and 200 mg/kg 
bw dose. Thus, Ag-NPs obtained by green synthesis provide 
a cheaper nontoxic method that ensures effectiveness and 
safety in the application of these nanoparticles in different 
fields of study.86 Finally, in the skin directly exposed to 
Ag-NPs, no adverse effects or interactions between tissue and 
the nanoparticles were found, since there were no alterations 
or changes in the appearance and structure of the treated 
skin. Therefore, the Ag-NPs at the tested concentration are 
safe for use in topical medical applications as an alternative 
antimicrobial therapeutic.
Conclusion
The use of the extract, obtained from roots and stems of 
A. rigidula, as a reducing and stabilizing agent represents a 
suitable alternative to produce antimicrobial metal nanopar-
ticles (green synthesis). The synthesis reported here provides 
many advantages over conventional synthesis methods, such 
as the use and production of less toxic reagent and products. 
This allows for greater care of the environment. Currently, in 
the field of pharmacology and toxicology, there is a great 
need for better nontoxic treatment options that are more 
effective and have better antimicrobial activity against 
infectious diseases caused by different types of bacteria, 
especially against multidrug-resistant clinical strains. The 
antimicrobial properties shown by the Ag-NPs reported here 
represent a great alternative to achieve this objective. The 
results reported in this work are relevant to the field since 
they represent a contribution toward the development of 
more efficient and nontoxic alternatives for pharmacologi-
cal treatments, taking advantage of the tools developed by 
nanotechnology. Nevertheless, further research in this subject 
is required to elucidate completely the interaction mechanism 
between Ag-NPs and bacteria. Moreover, research in phar-
macological and toxicological studies, especially in vivo, 
is much needed to develop and design future antimicrobial 
therapeutic agents.
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